GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED – MIA 5866
| Authorisation Number | UK MIA 5866 |
| Category | MIA |
| Holder | GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED |
| Registered Address | GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED, 79 NEW OXFORD STREET, LONDON, WC1A 1DG, UNITED KINGDOM |
| Authorisation Date | Apr 22, 2026 |
| Legal Basis | HumanRegulation 17 of The Human Medicines Regulations 2012 (SI 2012/1916) |
| Sites | 1 |
| Manufacturing Operations | 1.1 1.1.3 1.2 1.2.2 1.3 1.3.2 1.3.2.5 1.5 1.5.1 1.5.1.1 1.5.1.13 1.5.2 |
| Importation Operations | 2.2 2.2.1 2.2.1.1 2.2.1.2 2.2.2 2.2.3 2.2.3.5 2.2.3.8 2.3 2.3.1 2.3.2 |
| MHRA Link | View on MHRA Website |
Sites (1)
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
BOTH
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.1 — Sterile Products
1.1.3 — Batch certification
1.2 — Non-sterile products
1.2.2 — Batch certification
1.3 — Biological medicinal products
1.3.2 — Batch certification
1.3.2.5 — Biotechnology products
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.5.1.13 — Tablets
1.5.2 — Secondary packaging
Importation
2.2 — Batch certification of imported medicinal products
2.2.1 — Sterile Products
2.2.1.1 — Aseptically prepared
2.2.1.2 — Terminally sterilised
2.2.2 — Non-sterile products
2.2.3 — Biological medicinal products
2.2.3.5 — Biotechnology products
2.2.3.8 — Other biological medicinal products
2.3 — Other Importation Activities
2.3.1 — Site of Physical Importation
2.3.2 — Importation of Intermediate which undergoes further processing
Content Preview
The source document is available on KeyPedia. Sign in to view.